Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/EJE-07-0143
European Journal of Endocrinology, Vol 157, Issue 2, 201-207
Copyright © 2007 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahn, S.
Right arrow Articles by Janssen, O. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahn, S.
Right arrow Articles by Janssen, O. E
CLINICAL STUDY

Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism

Susanne Hahn, Manuel Backhaus1, Martina Broecker-Preuss1,2, Susanne Tan1, Tiina Dietz1, Rainer Kimmig3, Markus Schmidt3, Klaus Mann1 and Onno E Janssen4

Endokrinologikum Ruhr, Center for Endocrine and Metabolic Diseases, Alter Markt 4, 44866 Bochum, Germany, 1 Division of Endocrinology, Department of Medicine, 2 Division of Clinical Chemistry and Laboratory Medicine and 3 Department of Obstetrics and Gynecology, University Hospital of Essen Medical School, 45122 Essen, Germany and 4 Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, 60611 Chicago, Illinois, USA

(Correspondence should be addressed to S Hahn; Email: mail{at}susannehahn.com)

Objective: Insulin resistance and obesity are common features of the polycystic ovary syndrome (PCOS). Retinol-binding protein 4 (RBP4), a new fat-derived adipokine, has been described to be elevated in obesity and type 2 diabetes. The aim of the present study was to investigate whether serum RBP4 levels are correlated with metabolic parameters, indices of insulin resistance, and endocrine variables in German PCOS women.

Design: We assessed the correlation between metabolic and endocrine parameters with RBP4 levels in 200 PCOS patients and 64 healthy controls.

Methods: Serum RBP4 was measured by enzyme-linked immunosorbent assay (Immundiagnostik AG, Bensheim, Germany). In addition, anthropometric variables, clinical signs of hyperandrogenism, and body fat were evaluated, and a glucose tolerance test was performed to assess parameters of insulin resistance and glucose metabolism.

Results: Taking the entire PCOS cohort, RBP4 levels were positively correlated with body mass index (BMI), body fat, waist circumference, fasting glucose, and area under the curve for glucose (all P<0.05), but not with indices of insulin resistance. On the other hand, PCOS women with impaired glucose metabolism had higher RBP4 levels than PCOS women with normal glucose metabolism (median 30.6, range 23.3–73.9 versus median 26.3, range 6.4–61.4, P<0.05). Furthermore, no differences were found in RBP4 levels between lean PCOS women and BMI-matched healthy controls.

Conclusion: In German PCOS women, serum RBP4 levels are associated with obesity and parameters of glucose metabolism but not with PCOS per se.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
E. Aigner, N. Bachofner, K. Klein, C. De Geyter, F. Hohla, W. Patsch, and C. Datz
Retinol-Binding Protein 4 in Polycystic Ovary Syndrome--Association with Steroid Hormones and Response to Pioglitazone Treatment
J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1229 - 1235.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Rasouli and P. A. Kern
Adipocytokines and the Metabolic Complications of Obesity
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11_Supplement_1): s64 - s73.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. P. Mills, H. C. Furr, and S. A. Tanumihardjo
Retinol to Retinol-Binding Protein (RBP) Is Low in Obese Adults due to Elevated apo-RBP
Experimental Biology and Medicine, October 1, 2008; 233(10): 1255 - 1261.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. M. Barber, M. Hazell, C. Christodoulides, S. J. Golding, C. Alvey, K. Burling, A. Vidal-Puig, N. P. Groome, J. A. H. Wass, S. Franks, et al.
Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2859 - 2865.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. K. Hutchison, C. Harrison, N. Stepto, C. Meyer, and H. J. Teede
Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
Diabetes Care, July 1, 2008; 31(7): 1427 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Reinehr, B. Stoffel-Wagner, and C. L. Roth
Retinol-Binding Protein 4 and Its Relation to Insulin Resistance in Obese Children before and after Weight Loss
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2287 - 2293.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Mohlig, M. O Weickert, E. Ghadamgahi, A. M Arafat, J. Spranger, A. F H Pfeiffer, and C. Schofl
Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
Eur. J. Endocrinol., April 1, 2008; 158(4): 517 - 523.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 European Society of Endocrinology.